Authorization for Disclosure
An authorization for disclosure is a signed document in which a patient gives a healthcare provider or health plan permission to share their protected health information (PHI) for purposes not otherwise allowed without permission. In most cases, a covered entity must obtain this authorization from the patient before disclosing PHI for reasons beyond those the Privacy Rule already permits, such as treatment, payment, or healthcare operations. It should not be confused with the everyday sense of consent, because under HIPAA it has a specific, regulated meaning and required content.
Under the HIPAA Privacy Rule, an authorization for disclosure is a signed, patient-executed instrument that permits a covered entity to use or disclose specified protected health information (PHI) for purposes that generally fall outside the uses and disclosures otherwise permitted or required without authorization (for example, disclosures beyond treatment, payment, and healthcare operations). A valid authorization is generally required before disclosing PHI for any purpose not detailed in the applicable Privacy Rule provisions, and the Privacy Rule specifies required elements and statements that such an authorization must contain to be valid; readers should verify the specific required elements and the relevant CFR provisions against the current regulatory text. This term is distinct from 'consent' in the general sense and applies to PHI in all forms under the Privacy Rule, not solely electronic PHI. Note that state law, the HITECH Act, or other frameworks may impose additional or more stringent requirements, and form templates used by other agencies (such as the SSA-827) are designed to satisfy particular disclosure contexts and should be evaluated for HIPAA sufficiency independently.
Why it matters
The authorization for disclosure is one of the primary mechanisms through which the HIPAA Privacy Rule protects patient control over sensitive health information. Without a valid authorization, a covered entity generally may not disclose PHI for purposes that fall outside those the Privacy Rule already permits or requires, such as treatment, payment, and healthcare operations. This makes the authorization a critical gatekeeping tool: it draws the line between disclosures a provider or health plan may make routinely and those that require the patient's explicit, documented permission. Getting this wrong in either direction, disclosing without a required authorization, or refusing to disclose when a valid one exists, can create compliance exposure.
Because the Privacy Rule specifies particular required elements and statements an authorization must contain to be valid, form quality matters. An authorization that is missing required content, or that is used outside the disclosure context it was designed for, may not be a valid basis for disclosure under HIPAA. This is why templates developed by other agencies for their own purposes, such as the SSA-827 used in Social Security disability determinations, are built to satisfy a specific disclosure context and should be evaluated independently for HIPAA sufficiency rather than assumed to be interchangeable.
Compliance officers should also recognize that HIPAA sets a federal floor, not a ceiling. State law, the HITECH Act, or other frameworks may impose additional or more stringent requirements, for example, heightened protections for certain categories of especially sensitive information. Readers should verify the specific required elements and applicable CFR provisions against the current regulatory text, and should not treat any single template as automatically compliant across all jurisdictions and disclosure scenarios.
Who it's relevant to
Inside Authorization for Disclosure
Common questions
Answers to the questions practitioners most commonly ask about Authorization for Disclosure.